Self‐Assembly of Oriented Antibody‐Decorated Metal–Organic Framework Nanocrystals for Active‐Targeting Applications. Issue 21 (2nd January 2022)
- Record Type:
- Journal Article
- Title:
- Self‐Assembly of Oriented Antibody‐Decorated Metal–Organic Framework Nanocrystals for Active‐Targeting Applications. Issue 21 (2nd January 2022)
- Main Title:
- Self‐Assembly of Oriented Antibody‐Decorated Metal–Organic Framework Nanocrystals for Active‐Targeting Applications
- Authors:
- Alt, Karen
Carraro, Francesco
Jap, Edwina
Linares‐Moreau, Mercedes
Riccò, Raffaele
Righetto, Marcello
Bogar, Marco
Amenitsch, Heinz
Hashad, Rania A.
Doonan, Christian
Hagemeyer, Christoph E.
Falcaro, Paolo - Abstract:
- Abstract: Antibody (Ab)‐targeted nanoparticles are becoming increasingly important for precision medicine. By controlling the Ab orientation, targeting properties can be enhanced; however, to afford such an ordered configuration, cumbersome chemical functionalization protocols are usually required. This aspect limits the progress of Abs‐nanoparticles toward nanomedicine translation. Herein, a novel one‐step synthesis of oriented monoclonal Ab‐decorated metal–organic framework (MOF) nanocrystals is presented. The crystallization of a zinc‐based MOF, Zn2 (mIM)2 (CO3 ), from a solution of Zn 2+ and 2‐methylimidazole (mIM), is triggered by the fragment crystallizable (Fc) region of the Ab. This selective growth yields biocomposites with oriented Abs on the MOF nanocrystals (MOF*Ab): the Fc regions are partially inserted within the MOF surface and the antibody‐binding regions protrude from the MOF surface toward the target. This ordered configuration imparts antibody–antigen recognition properties to the biocomposite and shows preserved target binding when compared to the parental antibodies. Next, the biosensing performance of the system is tested by loading MOF*Ab with luminescent quantum dots (QD). The targeting efficiency of the QD‐containing MOF*Ab is again, fully preserved. The present work represents a simple self‐assembly approach for the fabrication of antibody‐decorated MOF nanocrystals with broad potential for sensing, diagnostic imaging, and targeted drug delivery.Abstract: Antibody (Ab)‐targeted nanoparticles are becoming increasingly important for precision medicine. By controlling the Ab orientation, targeting properties can be enhanced; however, to afford such an ordered configuration, cumbersome chemical functionalization protocols are usually required. This aspect limits the progress of Abs‐nanoparticles toward nanomedicine translation. Herein, a novel one‐step synthesis of oriented monoclonal Ab‐decorated metal–organic framework (MOF) nanocrystals is presented. The crystallization of a zinc‐based MOF, Zn2 (mIM)2 (CO3 ), from a solution of Zn 2+ and 2‐methylimidazole (mIM), is triggered by the fragment crystallizable (Fc) region of the Ab. This selective growth yields biocomposites with oriented Abs on the MOF nanocrystals (MOF*Ab): the Fc regions are partially inserted within the MOF surface and the antibody‐binding regions protrude from the MOF surface toward the target. This ordered configuration imparts antibody–antigen recognition properties to the biocomposite and shows preserved target binding when compared to the parental antibodies. Next, the biosensing performance of the system is tested by loading MOF*Ab with luminescent quantum dots (QD). The targeting efficiency of the QD‐containing MOF*Ab is again, fully preserved. The present work represents a simple self‐assembly approach for the fabrication of antibody‐decorated MOF nanocrystals with broad potential for sensing, diagnostic imaging, and targeted drug delivery. Abstract : A method for the integration of oriented antibodies in MOFs is proposed. A synchrotron small angle X‐ray scattering investigation demonstrates that the formation of the MOF (ZIF‐C) is induced by the crystallizable fragment region (Fc) of antibodies, leaving the fragment antigen‐binding (Fab) regions free to target antigens. ZIF‐C*antibody particles are functionalized with fluorescent markers for active targeting and cancer cell imaging. … (more)
- Is Part Of:
- Advanced materials. Volume 34:Issue 21(2022)
- Journal:
- Advanced materials
- Issue:
- Volume 34:Issue 21(2022)
- Issue Display:
- Volume 34, Issue 21 (2022)
- Year:
- 2022
- Volume:
- 34
- Issue:
- 21
- Issue Sort Value:
- 2022-0034-0021-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-01-02
- Subjects:
- antibodies -- crystallization -- metal–organic frameworks -- self‐assembly -- targeting
Materials -- Periodicals
Chemical vapor deposition -- Periodicals
620.11 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-4095 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/adma.202106607 ↗
- Languages:
- English
- ISSNs:
- 0935-9648
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0696.897800
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21732.xml